DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Cells constantly face DNA damage, necessitating repair mechanisms for survival.
• DNA repair accuracy is vital; inaccuracies can cause genomic instability and cancer.
• Multiple myeloma (MM) is a cancer of malignant plasma cells, characterized by genetic instability.

Purpose of the Study:

• To review the current understanding of DNA repair in multiple myeloma.
• To explore the links between molecular features, treatment, and DNA repair in MM.
• To identify potential therapeutic targets within DNA repair pathways.

Main Methods:

• Literature review of current knowledge on DNA repair in multiple myeloma.
• Analysis of the role of DNA repair in MM pathogenesis and progression.
• Examination of the impact of MM treatments on DNA repair pathways.

Main Results:

• Aberrant DNA repair pathways are implicated in the onset, translocations, and progression of MM.
• Key MM drugs, Melphalan and Bortezomib, directly affect DNA repair mechanisms.
• DNA repair pathways influence both treatment response and resistance in MM.

Conclusions:

• Understanding DNA repair in MM is critical for improving disease treatment.
• Targeting specific DNA repair pathways holds promise for novel MM therapies.
• Aberrant DNA repair is a key feature contributing to MM development and progression.